CARLChats: How COVID-19 has affected Biotech's Supply Chain скачать в хорошем качестве

CARLChats: How COVID-19 has affected Biotech's Supply Chain

In today’s global marketplace, antibodies and supporting reagents are sourced from many parts of the globe. For instance, considerable manufacturing and raw material supply for life science reagents originates in Asia. The SARS-CoV-2 pandemic saw a total shutdown of this region, which affected many diverse multibillion-dollar industries. Going forward, risk mitigation strategies should be developed and deployed to take proactive measures to ensure uninterrupted access to critical supply chain materials. See what Rockland's Chief Scientific Officer, Dr. Carl Ascoli and Product Manager, Todd Giardiello have to say: Contents: 00:00 Intro 00:58 Why do some coronaviruses cause colds while COVID-19 causes more severe affects? 01:37 How have collaborations with academic institutions helped with understanding SARS-CoV-2? 03:06 How did COVID-19 shine a light on biotech's supply chain strategies? 04:38 What are the main obstacles in establishing long-term supply chain? 07:12 What other immunoassay critical reagents can be affected by supply chain instability? 09:07 How can critical reagent suppliers help diagnostic manufacturers? ► Learn more about Rockland's COVID-19 Critical Reagents: https://rockland-inc.com/COVID19.aspx ► Learn more about Rockland's In Vitro Diagnostic Services & Raw Materials: https://rockland-inc.com/IVD.aspx ______________ #Covid-19 #biotech #supplychain #antibodies #reagents